Which pharmaceutical company pioneered the now-common practice of color-coding inhaler medications by therapeutic class (e.g., blue for rescue/relief, green for prevention), significantly improving patient medication adherence?

In the competitive medical industry, pharmaceutical companies invest heavily in brand strategy to differentiate their products. Visual identity elements like logos, colors, and packaging design play crucial roles in building trust with healthcare providers and patients. This poll tests your knowledge about a revolutionary branding decision that changed how prescription medications are perceived and recognized in the market.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

GlaxoSmithKline (GSK) with their Ventolin/Seretide inhalers in the 1980s
AstraZeneca with their Symbicort inhaler product line in the early 2000s
Boehringer Ingelheim when launching their Spiriva respiratory franchise in 1995
Teva Pharmaceuticals as part of their generic inhaler strategy in 2010